The RET proto-oncogene is at the origin of the one of the most interes
ting models of human disease caused by mutations in a receptor tyrosin
e kinase gene. Somatic rearrangements of RET are involved in the aetio
logy of a variable proportion of papillary thyroid carcinomas (PTC), t
he most common type of thyroid tumour whose prevalence is increasing i
n areas heavily exposed to radioactive fallout after the Chernobyl acc
ident of 1986. Moreover, germline RET mutations are associated with th
e three variants of the inherited cancer syndrome known as multiple en
docrine neoplasia type 2 (MEN2A, MEN2B and FMTC). Finally, RET mutatio
ns or heterozygous deletions of the whole gene cause the autosomal dom
inant form of Hirschsprung disease (HSCR), a congenital disorder of th
e enteric nervous system (ENS).